Opioid Settlement Prevention, Treatment and Recovery Board

OSPTR Board Purpose

The Opioid Settlement Prevention, Treatment and Recovery Board (OSPTR Board) will determine how to allocate the State’s portion of Oregon’s opioid settlement funds. The OSPTR Board’s role and membership were established by the Oregon State Legislature in March 2022 through House Bill 4098.

OHA provides staff support and works with OSPTR Board members to convene and organize Board meetings. If you would like to submit a letter or statement to the OSPTR Board, please send it to Lisa.m.shields@dhsoha.state.or.us.

OSPTR Board Timeline (View full-sized image)

For more information on Oregon's opioid settlement funds, visit www.oregon.gov/opioidsettlement

1. A policy advisor to the Governor *Temporarily vacant*
2. A representative of the Department of Justice, David Hart, Sr. Assistant Attorney General, Department of Justice
3. A representative of the Oregon Health Authority ** John W. McIlveen, PhD, LMHC**, State Opioid Treatment Authority, Oregon Health Authority
4. A representative of the Department of Human Services Tami Kane-Suleiman, MSW, Child Fatality Prevention & Review Program Manager, Oregon Department of Human Services
5. The Director of the Alcohol and Drug Policy Commission Annaliese Dolph Director, Alcohol and Drug Policy Commission Oregon Health Authority
6. The Chairperson of the Oversight and Accountability Council established in ORS 430.388 or designee Zebuli Payne, CADCII Clinical Director Phoenix Wellness Center
7. An individual representing Clackamas, Washington, or Multnomah County Nicholas Ocón, LCSW, Behavioral Health Division Manager, Washington County Dept. of Health and Human Services
8. An individual representing Clatsop, Columbia, Coos, Curry, Jackson, Josephine, Lane, or Yamhill County Laurie Trieger, Lane County Commissioner
9. An individual representing the City of Portland Skyler Brocker-Knapp, BA, MA, JD, Senior Policy Advisor to Portland Mayor
10. An individual representing a city with a population above 10,000 residents as of July 21, 2021 Dr. Joann Linville Wilsonville City Councilor
11. An individual representing a city with a population at or below 10,000 residents as of July 21, 2021 Julia Hajduk, Community Development Director, City of Stayton
12. A representative of the Oregon Coalition of Local Health Officials Carrie Brogoitti, Director of Public Health, Union County Center for Human Development
13. A representative of a community mental health program Rick Treleaven, LCSW, Chief Executive Officer, BestCare Treatment Services, Inc.
14. An individual who has experienced a substance use disorder or a representative of an organization that advocates on behalf of individuals with substance use disorders Fernando Peña, Executive Director, NW Instituto Latino
15. An individual representing law enforcement, first responders, or jail commanders or wardens Captain Lee Eby, Jail Commander Clackamas County Sheriff's Office
16. A member of the House of Representatives appointed by the Speaker of the House of Representatives (nonvoting) Maxine Dexter, MD, Oregon State Representative
17. A member of the Senate appointed by the President of the Senate (nonvoting) Lew Frederick, Oregon State Senator
18. The State Court Administrator (nonvoting) Ann Lininger, Clackamas County Circuit Court Judge

OSPTR Board members will serve four-year terms and are eligible for reappointment. Ex-officio members will serve on the OSPTR Board based on the mandated member representation (for example, the Director of the Alcohol and Drug Policy Commission). Before a member’s term expires, the department shall appoint a successor whose term will begin January 1 of the following term. If there is a vacancy for any cause, the department shall make an appointment to become effective immediately.

Read the OSPTR Board By-Laws

Statutory Rules of Operation

Statute lists the following rules of operation for the OSPTR Board:

The Governor shall select one co-chairperson from the members in positions #1-12 to represent state entities
Members in positions #13-18 shall select a co-chairperson from one of their members to represent cities or counties
The Oregon Health Authority shall provide staff support to the board
Decision-making by the board shall be based on consensus and supported by at least a majority of the members
The board shall document all objections to board decisions
The board shall conduct at least four public meetings in accordance with Oregon's public meeting law. They willl be publicized to facilitate attendance, and the board will receive testimony and input from the community during the meetings
The board shall establish a process for the public to provide written comments and proposals at each meeting of the board
The board shall be guided and informed by:
1. The comprehensive 2020 - 2025 Addiction, Prevention, Treatment and Recovery Plan developed by the Alcohol and Drug Policy Commission
2. The board’s ongoing evaluation of the efficacy of the funding allocations
3. Evidence-based and evidence-informed strategies and best practices
4. Input the board receives from the public
5. Equity considerations for underserved populations
6. The terms of the settlement agreements

Satutory Rules of Fund Allocation

Statute lists the following rules for determining how the State’s portion of Oregon’s opioid settlement funds may be allocated:

No more than five percent of the moneys may be spent on administering the board and the fund
A portion of the moneys shall be allocated toward a unified and evidence-based state system for collecting, analyzing and publishing data about the availability and efficacy of substance use prevention, treatment and recovery services statewide
Opioid settlement funds shall be allocated for funding evidence-based or evidence-informed statewide and regional programs identified in the Distributor Settlement Agreement, the Janssen Settlement Agreement and any other judgment or judgment or settlement described in section 5 (1)(c) of 2022 HB4098, including but not limited to programs that:
1. Treat opioid use disorders and any co-occurring substance use disorders or mental health conditions
2. Support individuals in recovery from opioid use disorders and any co-occurring substance use disorders or mental health conditions
3. Provide connections to care for individuals who have or are at risk of developing opioid use disorders and any co-occurring substance use disorders or mental health conditions
4. Address the needs of individuals with opioid use disorders and any co-occurring substance use disorders or mental health conditions and who are involved in, at risk of becoming involved in, or in transition from, the criminal justice system
5. Address the needs of pregnant or parenting women with opioid use disorders and any co-occurring substance use disorders or mental health conditions, and the needs of their families, including babies with neonatal abstinence syndrome
6. Support efforts to prevent over-prescribing of opioids and ensure appropriate prescribing and dispensing of opioids
7. Support efforts to discourage or prevent misuse of opioids
8. Support efforts to prevent or reduce overdose deaths or other opioid-related harms
9. Educate law enforcement or other first responders regarding appropriate practices and precautions when dealing with users of fentanyl or other opioids
10. Provide wellness and support services for first responders and others who experience secondary trauma associated with opioid-related emergency events
11. Support efforts to provide leadership, planning, coordination, facilitation, training and technical assistance to abate the opioid epidemic through activities, programs or strategies
12. Provide funding to support opioid abatement research

Upcoming Meetings

Recent Meetings

Archived Meetings

All Archived Meetings